Meta-analysis on the association between the TF gene rs1049296 and AD

Canadian Journal of Neurological Sciences

Volumn 40, Issue 5, 2013, Pages 691-697

  Wang, Yun ^a   Xu, Shunliang ^a   Liu, Zhen ^a   Lai, Chao ^a   Xie, Zhaohong ^a   Zhao, Cuiping ^a   Wei, Yan ^a   Bi, Jianzhong ^a  

^a THE SECOND HOSPITAL OF SHANDONG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

GENOMIC DNA; TRANSFERRIN;

ALLELE; ALZHEIMER DISEASE; ARTICLE; GENE FREQUENCY; GENETIC ASSOCIATION; GENOTYPE; HUMAN; META ANALYSIS; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 84883245898     PISSN: 03171671     EISSN: None     Source Type: Journal    
DOI: 10.1017/S0317167100014931     Document Type: Article

References (48)

1. bertram l, Tanzi Re. The current status of Alzheimer's disease genetics: What do we tell the patients? Pharmacol Res. 2004;50: 385-96.
2. Strittmatter WJ, Saunders Am, Schmechel D, et al. Apolipoprotein e: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc Natl Acad Sci USA. 1993;90:1977-81.
3. Daw eW, Payami H, Nemens eJ, et al. The number of trait loci in late-onset Alzheimer disease. Am J Hum genet. 2000;66: 196-204.
4. Connor JR, menzies Sl, St martin Sm, mufson eJ. A histochemical study of iron, transferrin, and ferritin in Alzheimer's disease brains. J Neurosci Res. 1992;31:75-83.
5. van Rensburg SJ, Carstens me, Potocnik FC, et al. Transferrin C2 and Alzheimer's disease: another piece of the puzzle found? med Hypotheses. 1995;44:268-72.
6. Ding b, Chen Km, ling HW, et al. Correlation of iron in the hippocampus with mmSe in patients with Alzheimer's disease. J magn Reson Imaging. 2009;29:793-8.
7. Jiang D, li X, Williams R, et al. Ternary complexes of iron, amyloid-beta, and nitrilotriacetic acid: binding affinities, redox properties, and relevance to iron-induced oxidative stress in Alzheimer's disease. biochemistry. 2009;48:7939-47.
8. van Rensburg SJ, Carstens me, Potocnik FC, Aucamp AK, Taljaard JJ. Increased frequency of the transferrin C2 subtype in Alzheimer's disease. Neuroreport. 1993;4:1269-71.
9. lehmann DJ, Schuur m, Warden DR, et al. Transferrin and HFe genes interact in Alzheimer's disease risk: the epistasis Project. Neurobiol Aging. 2012;33:202.e1-13.
10. giambattistelli F, bucossi S, Salustri C, et al. effects of hemochromatosis and transferring gene mutations on iron dyshomeostasis, liver dysfunction and on the risk of Alzheimer's disease. Neurobiol. 2011;33:1633-41.
11. Kauwe JS, bertelsen S, mayo K, et al. Alzheimer's disease neuroimaging initiative. Suggestive synergy between genetic variants in TF and HFe as risk factors for Alzheimer's disease. Am J med genet. b Neuropsychiatr. genet. 2010;153b:955-9.
12. laumet g, Chouraki v, grenier-boley b, et al. Systematic analysis of candidate genes for Alzheimer's disease in a French, genome-wide association study. J Alzheimers Dis. 2010;20: 1181-8.
13. giedraitis v, Kilander l, Degerman-gunnarsson m, et al. genetic analysis of Alzheimer's disease in the Uppsala longitudinal Study of Adult men. Dement geriatr Cogn Disord. 2009;27: 59-68.
14. li H, Wetten S, li l, et al. Candidate single-nucleotide polymorphisms from a genomewide association study of Alzheimer disease. Arch Neurol. 2008;65:45-53.
15. Reiman em, Webster JA, myers AJ, et al. gAb2 alleles modify Alzheimer's risk in APoe epsilon4 carriers. Neuron. 2007;54: 713-20.
16. blázquez l, De Juan D, Ruiz-martínez J, et al. genes related to iron metabolism and susceptibility to Alzheimer's disease in basque population. Neurobiol Aging. 2007;28:1941-3.
17. Rondeau v, Iron A, letenneur l, et al. Analysis of the effect of aluminum in drinking water and transferrin C2 allele on Alzheimer's disease. eur J Neurol. 2006;13:1022-5.
18. Robson KJ, lehmann DJ, Wimhurst vl, et al. Synergy between the C2 allele of transferrin and the C282Y allele of the haemochromatosis gene (HFe) as risk factors for developing Alzheimer's disease. J med genet. 2004;41:261-5.
19. Corder eH, beaumont H. Susceptibility groups for Alzheimer's disease (oPTImA cohort): integration of gene variants and biochemical factors. mech Ageing Dev. 2007;128:76-82.
20. lehmann DJ, Worwood m, ellis R, et al. Iron genes, iron load and risk of Alzheimer's disease. J med genet. 2006;43:e52.
21. Zambenedetti P, De bellis g, biunno I, musicco m, Zatta P. Transferrin C2 variant does confer a risk for Alzheimer's disease in caucasians. J Alzheimers Dis. 2003;5:423-7.
22. lleó A, blesa R, Angelopoulos C, et al. Transferrin C2 allele, haemochromatosis gene mutations, and risk for Alzheimer's disease. J Neurol Neurosurg Psychiatry. 2002;72:820-1.
23. Hussain RI, ballard Cg, edwardson JA, morris Cm. Transferrin gene polymorphism in Alzheimer's disease and dementia with lewy bodies in humans. Neurosci lett. 2002;17:13-16.
24. emahazion T, Feuk l, Jobs m, et al. SNP association studies in Alzheimer's disease highlight problems for complex disease analysis. Trends genet. 2001;17:407-13.
25. van landeghem gF, Sikström C, beckman le, Adolfsson R, beckman l. Transferrin C2, metal binding and Alzheimer's disease. Neuroreport. 1998;9:177-9.
26. Zhang P, Yang Z, Zhang C, et al. Association study between lateonset Alzheimer's disease and the transferrin gene polymorphisms in Chinese. Neurosci lett. 2003;349:209-11.
27. Kim KW, Jhoo JH, lee JH, et al. Transferrin C2 variant does not confer a risk for Alzheimer's disease in Koreans. Neurosci lett. 2001;308:45-8.
28. Kim KW, Jhoo JH, lee JH, et al. Neither the butyrylcholinesterase K variant nor transferrin C2 variant confers a risk for Alzheimer's disease in Koreans. J Neural Transm. 2001;108: 1159-66.
29. Namekata K, Imagawa m, Terashi A, et al. Association of transferrin C2 allele with late-onset Alzheimer's disease. Hum genet. 1997;101:126-9.
30. van Rensburg SJ, Potocnik FC, De villiers JN, Kotze mJ, Taljaard JJ. earlier age of onset of Alzheimer's disease in patients with both the transferrin C2 and apolipoprotein e-epsilon 4 alleles. Ann N Y Acad Sci. 2000;903:200-3.
31. American Psychiatric Association. Diagnostic and Statistical manual of mental Disorders 4th ed. Washington DC: American Psychiatric Association; 1994. p. 37-9.
32. mcKhann g, Drachman D, Folstein m, et al. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease. Neurology. 1984; 34:939-44.
33. mirra SS, Heyman A, mcKeel D, et al. The Consortium to establish a Registry for Alzheimer's Disease (CeRAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology. 1991;41:479-86.
34. lau J, Ioannidis JP, Schmid CH. Quantitative synthesis in systematic reviews. Ann Intern med. 1997;127:820-6.
35. Higgins JP, Thompson Sg, Deeks JJ, Altman Dg. measuring inconsistency in meta-analyses. br med J. 2003;327:557-60.
36. mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst. 1959; 22:719-48.
37. DerSimonian R, laird N. meta analysis in clinical trials. Control Clin Trials. 1986;7:177-88.
38. galbraith RF. A note on graphical presentation of estimated odds ratios from several clinical trials. Stat med. 1988;7:889-94.
39. egger m, Davey Smith g, Schneider m, minder C. bias in meta analysis detected by a simple, graphical test. br med J. 1997; 315: 629-34.
40. Shi H, belbin o, medway C, et al. genetic variants influencing human aging from late-onset Alzheimer's disease (loAD) genome-wide association studies (gWAS). Neurobiol Aging. 2012;33:1849.e5-18.
41. butterfield DA. Amyloid beta-peptide (1-42)-induced oxidative stress and neurotoxicity: implications for neurodegeneration in Alzheimer's disease brain. A review. Free Radic Res. 2002;36: 1307-13.
42. venkateshappa C, Harish g, mahadevan A, et al. elevated oxidative stress and decreased antioxidant function in the human hippocampus and frontal cortex with increasing age: implications for neurodegeneration in Alzheimer's disease. Neurochem Res. 2012;37:1601-14.
43. bush AI, Tanzi Re. Therapeutics for Alzheimer's disease based on the metal hypothesis. Neurotherapeutics. 2008;5:421-32.
44. Horowitz mP, greenamyre JT. mitochondrial iron metabolism and its role in neurodegeneration. J Alzheimers Dis. 2010;20 Suppl 2:S551-68.
45. Smith mA, Zhu X, Tabaton m, et al. Increased iron and free radical generation in preclinical Alzheimer disease and mild cognitive impairment. J Alzheimers Dis. 2010;19:363-72.
46. macedo mF, de Sousa m. Transferrin and the transferrin receptor: of magic bullets and other concerns. Inflamm Allergy Drug Targets. 2008;7:41-52.
47. bertram l, mcQueen mb, mullin K, blacker D, Tanzi Re. Systematic meta-analyses of Alzheimer disease genetic association studies: the Alzgene database. Nat genet. 2007;39: 17-23.
48. Schjeide bm, mcQueen mb, mullin K, et al. Assessment of Alzheimer's disease case-control associations using familybased methods. Neurogenetics. 2009;10:19-25.